Dawson James Upgrades Antares Pharma (AIS) to Buy; Injecting Some Excitement

April 19, 2011 9:37 AM EDT Send to a Friend
Dawson James upgrades Antares Pharma (NYSE: AIS) to Buy with a $2.50 price target.

Dawson analyst says, "Antares had a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login